Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Pre-SET motif family protein | 0.0203 | 0.5137 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0582 | 0.0483 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0063 | 0.0971 | 0.0876 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0183 | 0.0115 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0604 | 0.0955 |
Schistosoma mansoni | hypothetical protein | 0.0367 | 1 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0034 | 0.0104 | 0.0104 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.0604 | 0.0955 |
Trypanosoma brucei | ISWI complex protein | 0.0031 | 0 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0063 | 0.0971 | 0.0876 |
Schistosoma mansoni | lipoxygenase | 0.0056 | 0.0766 | 0.0766 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0183 | 0.0183 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0063 | 0.0971 | 0.0971 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0183 | 0.008 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0056 | 0.0766 | 0.0669 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.0604 | 0.0955 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0582 | 0.0483 |
Brugia malayi | Bromodomain containing protein | 0.0076 | 0.1366 | 0.2475 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0045 | 0.043 | 0.043 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0119 | 0.2637 | 0.256 |
Trypanosoma cruzi | ISWI complex protein | 0.0031 | 0 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0045 | 0.043 | 0.033 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.0582 | 0.0911 |
Loa Loa (eye worm) | hypothetical protein | 0.0141 | 0.3292 | 0.6317 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.137 | 0.2484 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0063 | 0.0971 | 0.0971 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0041 | 0.0317 | 0.0382 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0582 | 0.0582 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0125 | 0.0125 |
Schistosoma mansoni | hypothetical protein | 0.0367 | 1 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0203 | 0.5137 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0183 | 0.5 |
Echinococcus multilocularis | geminin | 0.0367 | 1 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0034 | 0.0104 | 0.0104 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0582 | 0.0483 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0183 | 0.008 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.1511 | 0.2764 |
Brugia malayi | PHD-finger family protein | 0.005 | 0.0571 | 0.0889 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.0604 | 0.0955 |
Trichomonas vaginalis | set domain proteins, putative | 0.0231 | 0.5973 | 0.5 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0045 | 0.043 | 0.033 |
Echinococcus granulosus | zinc finger protein | 0.0039 | 0.0254 | 0.0151 |
Trypanosoma cruzi | ISWI complex protein | 0.0031 | 0 | 0.5 |
Echinococcus multilocularis | zinc finger protein | 0.0039 | 0.0254 | 0.0151 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0183 | 0.0183 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0183 | 0.5 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0056 | 0.0766 | 0.0669 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.1624 | 0.2991 |
Leishmania major | hypothetical protein, conserved | 0.0031 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0183 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.0039 | 0.0254 | 0.0254 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0119 | 0.2637 | 0.256 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0582 | 0.0582 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0582 | 0.0483 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1225 | 0.1133 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0317 | 0.0317 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0183 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0126 | 0.285 | 0.285 |
Brugia malayi | Bromodomain containing protein | 0.015 | 0.3546 | 0.6824 |
Onchocerca volvulus | 0.0231 | 0.5973 | 0.5 | |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1225 | 0.1133 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0035 | 0.0141 | 0.003 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0971 | 0.1688 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.0582 | 0.0911 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0582 | 0.0582 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 101 % | Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control | ChEMBL. | 20472330 |
Activity (binding) | = 102 % | Inhibition of CDK5/p25 assessed as residual activity at 1 uM relative to control | ChEMBL. | 20472330 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.